首页|雷公藤多苷联合甲氨蝶呤治疗类风湿性关节炎短期疗效及对外周血IL-6、IL-10和TNF-α水平的影响

雷公藤多苷联合甲氨蝶呤治疗类风湿性关节炎短期疗效及对外周血IL-6、IL-10和TNF-α水平的影响

扫码查看
目的 探讨雷公藤多苷联合甲氨蝶呤治疗类风湿性关节炎(RA)短期疗效及对患者外周血IL-6、IL-10和TNF-α水平的影响.方法 通过对温州医科大学第三临床学院2014年2月~2016年8月收治的80例RA患者临床资料做回顾性分析.并根据治疗方式的不同分为观察组、对照组(各40例).比较并分析2组患者短期治疗疗效及治疗前后主要临床症状及体征变化和ESR、RF、CRP、TNF-α、IL-6、IL-10指标水平.结果 观察组的治疗总有效率(92.50%)明显高于对照组(77.50%),差异具有统计学意义(P<0.05).2组患者治疗前主要临床症状及体征比较差异无统计学意义;治疗后2组患者主要临床症状及体征均较治疗前有所缓解差异具有统计学意义(P<0.05),且观察组主要临床症状及体征均较对照组缓解(下降)明显,差异具有统计学意义(P<0.05).2组患者治疗前ESR、RF、CRP、TNF-α、IL-6、IL-10指标水平比较差异无统计学意义;治疗后2组患者ESR、RF、CRP、TNF-α、IL-6、IL-10指标水平均较治疗前比较差异具有统计学意义(P<0.05),且观察组ESR、RF、CRP、TNF-α、IL-6指标水平均较对照组下降明显,IL-10指标水平较对照组上升明显差异具有统计学意义(P<0.05).结论 雷公藤多苷联合甲氨蝶呤治疗类风湿性关节炎临床疗效显著,且可有效的抑制外周血清L-6、和TNF-α水平表达,促进IL-10水平表达,减轻炎症反应.
Effect of Tripterygium wilfordii combined with methotrexate on short-term effect of rheumatoid arthritis and the levels of IL-6, IL-10 and TNF- in peripheral blood
Objective To investigate the effects of tripterygium glycosides combined with methotrexate in treatment of rheumatoid arthritis (RA) curative effect and peripheral blood of patients with IL-6, effects of IL-10 and TNF- alpha. Methods 80 patients with RA from February 2014 to August 2016 in our hospital were retrospectively analyzed. According to the different treatment methods by for the observation group, the control group (40 cases). To compare and analyze the curative effect before and after short-term treatment and treatment of patients in the 2 groups were the main clinical symptoms and signs of change and ESR, RF, CRP, IL-6, TNF- alpha, IL-10 index. Results The total effective rate of observation group (92.50%) was significantly higher than the control group (77.50%), the difference was statistically significant (P<0.05), 2 groups of patients before treatment of main clinical symptoms and signs, there was no significant difference, after treatment, clinical symptoms and signs of 2 groups of patients were compared with those before treatment was statistically significant to alleviate the differences (P<0.05), and the observation group of main clinical symptoms and signs were lower than the control group and the remission (down), the difference was statistically significant (P<0.05).Before ESR, the treatment of 2 patients with RF, CRP, TNF- IL-6, alpha, IL-10 index level, no statistical significance, the 2 groups after treatment in patients with ESR, RF, CRP, IL-6, TNF- alpha, IL-10 index level than before treatment with significant difference (P<0.05), and the observation group ESR, RF, CRP, TNF- alpha, IL-6 average index of water compared with the control group decreased significantly, IL-10 index increased significantly than the control group. The difference was statistically significant (P<0.05). Conclusion Tripterygium glycosides combined with methotrexate in treatment of rheumatoid arthritis And it can effectively inhibit the expression of peripheral serum L-6 and TNF- alpha, promote the expression of IL-10 and alleviate the inflammatory reaction

tripterygium glycosidesmethotrexaterheumatoid arthritisshort-term efficacyinflammatory factors

王胜男、陈萍、林素仙、姜建昌、卢阳、张智勇、朱小春

展开 >

温州医科大学温州市第三临床学院,温州市人民医院风湿免疫科,浙江 温州 325000

温州医科大学附属第一医院风湿免疫科 ,浙江 温州 325000

雷公藤多苷 甲氨蝶呤 类风湿性关节炎 短期疗效 炎性因子

2017

中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
年,卷(期):2017.37(9)
  • 11
  • 15